ScreenerHero

ENZY Enzymatica AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · enzymatica.com
1.780SEK-0.56%Mkt Cap: 41.33M $P/E: —

Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that ca…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap41.33M USD
Enterprise Value41.66M USD
Revenue (TTM)4.97M USD
Gross Profit3.17M USD
Net Income (TTM)-4.96M USD
Revenue/Share0.21 SEK
Last Price1.780 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees18
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0003943620
Valuation
P/E (Trailing)—
P/E (Forward)-5.97
PEG—
EV/EBITDA-10.30
EV/Revenue8.39
P/S8.37
P/B4.42
EPS (TTM)-0.19
EPS (Forward)-0.30
52W Range
1.55012% of range3.400
52W High3.400 SEK
52W Low1.550 SEK
Profitability
Gross Margin61.45%
Oper. Margin-176.83%
EBITDA Margin-81.39%
Profit Margin-96.27%
ROE-41.79%
ROA-36.55%
Growth
Revenue Growth-13.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.92M USD
CapEx (TTM)22.10K USD
FCF Margin-27.64%
FCF Yield-3.32%
Net Debt97.76K USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.01
Current Ratio2.45
Quick Ratio1.48
Book Value/Sh0.41 SEK
Cash/Share0.05 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.242.74M
Float175.75M
Insiders63.16%
Institutions9.88%
Technical
SMA 501.876 (-5.1%)
SMA 2002.220 (-19.8%)
Beta-0.40
S&P 52W Chg14.58%
Avg Vol (30d)88.24K
Avg Vol (10d)89.37K
Technical Indicators
RSI (14)45.9
MACD-0.0629
MACD Signal-0.0622
MACD Hist.-0.0006
BB Upper2.189 SEK
BB Middle1.851 SEK
BB Lower1.513 SEK
BB Width36.50%
ATR (14)0.1245 SEK
Vol Ratio (20d)0.28x